Literature DB >> 25022941

Ischemic stroke in prediabetic patients.

Jaume Roquer1, Ana Rodríguez-Campello, Elisa Cuadrado-Godia, Eva Giralt-Steinhauer, Jordi Jiménez-Conde, Irene R Dégano, Angel Ois.   

Abstract

To describe the clinical characteristics of first-ever ischemic stroke (IS) patients with prediabetes, and to compare them with diabetes mellitus (DM) and non-DM patient characteristics. Retrospective analysis of a prospective series of first-ever acute IS patients. Patients were classified as non-DM (HbA1c during admission <5.7% and no previous evidence of 2 or more fasting glucose >126 mg/dL), prediabetes (HbA1c from 5.7 to 6.4%), and DM (previous DM diagnosis or HbA1c ≥6.5% independently of current blood glucose). Demographic and clinical characteristics were compared between the three groups, along with outcome data [early neurological deterioration (END), 3-month poor outcome, 3-month mortality, outcome after rtPA treatment]. No demographic differences were observed. Prediabetic patients had more arterial hypertension (p = 0.006) and higher waist circumference (p < 0.0001) than non-DM patients, and DM patients had more hypercholesterolemia (p < 0.0001), body mass index (p = 0.017), and coronary artery disease (p = 0.005) than prediabetics. There were differences in TOAST subtype distribution (p < 0.0001). There were no differences in rtPA treatment success rate between groups. Multivariate analysis adjusted by age and stroke severity showed that DM but not prediabetes is an independent factor associated with END and 3-month poor outcome. Prediabetic patients with IS exhibit an "intermediate" vascular risk factor profile between that of non-DM and DM patients. In contrast to DM patients, IS prognosis in patients with prediabetes is similar to non-DM patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25022941     DOI: 10.1007/s00415-014-7431-7

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  20 in total

1.  Abnormal glucose regulation in patients with acute stroke across China: prevalence and baseline patient characteristics.

Authors:  Qian Jia; Huaguang Zheng; Xingquan Zhao; Chunxue Wang; Gaifen Liu; Yilong Wang; Liping Liu; Hao Li; Liyong Zhong; Yongjun Wang
Journal:  Stroke       Date:  2012-01-19       Impact factor: 7.914

2.  Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients.

Authors:  Marc Ribo; Carlos Molina; Joan Montaner; Marta Rubiera; Raquel Delgado-Mederos; Juan F Arenillas; Manuel Quintana; José Alvarez-Sabín
Journal:  Stroke       Date:  2005-07-07       Impact factor: 7.914

3.  Disorders of glucose metabolism in acute stroke patients: an underrecognized problem.

Authors:  Karl Matz; Katharina Keresztes; Claudia Tatschl; Monika Nowotny; Alexandra Dachenhausen; Alexandra Dachenhausenm; Michael Brainin; Jaakko Tuomilehto
Journal:  Diabetes Care       Date:  2006-04       Impact factor: 19.112

4.  Abnormal glucose tolerance and increased risk for cardiovascular disease in Japanese-Americans with normal fasting glucose.

Authors:  D Liao; J B Shofer; E J Boyko; M J McNeely; D L Leonetti; S E Kahn; W Y Fujimoto
Journal:  Diabetes Care       Date:  2001-01       Impact factor: 19.112

5.  Impact of diabetes and prediabetes on the short-term prognosis in patients with acute ischemic stroke.

Authors:  Ryota Tanaka; Yuji Ueno; Nobukazu Miyamoto; Kazuo Yamashiro; Yasutaka Tanaka; Hideki Shimura; Nobutaka Hattori; Takao Urabe
Journal:  J Neurol Sci       Date:  2013-06-28       Impact factor: 3.181

6.  Acute stroke unit care and early neurological deterioration in ischemic stroke.

Authors:  Jaume Roquer; Ana Rodríguez-Campello; Meritxell Gomis; Jordi Jiménez-Conde; Elisa Cuadrado-Godia; Rosa Vivanco; Eva Giralt; Maria Sepúlveda; Claustre Pont-Sunyer; Gracia Cucurella; Angel Ois
Journal:  J Neurol       Date:  2008-06-02       Impact factor: 4.849

7.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

Review 8.  Prediabetes: a high-risk state for diabetes development.

Authors:  Adam G Tabák; Christian Herder; Wolfgang Rathmann; Eric J Brunner; Mika Kivimäki
Journal:  Lancet       Date:  2012-06-09       Impact factor: 79.321

9.  Association of prediabetes and diabetes with stroke symptoms: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.

Authors:  April P Carson; Paul Muntner; Brett M Kissela; Dawn O Kleindorfer; Virginia J Howard; James F Meschia; Linda S Williams; Ronald J Prineas; George Howard; Monika M Safford
Journal:  Diabetes Care       Date:  2012-06-14       Impact factor: 19.112

10.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

View more
  11 in total

Review 1.  Prediabetes and Cardiovascular Disease: Pathophysiology and Interventions for Prevention and Risk Reduction.

Authors:  Ben Brannick; Sam Dagogo-Jack
Journal:  Endocrinol Metab Clin North Am       Date:  2018-03       Impact factor: 4.741

2.  The initial glycemic variability is associated with early neurological deterioration in diabetic patients with acute ischemic stroke.

Authors:  Jiaojie Hui; Jianping Zhang; Xuqiang Mao; Zaiwang Li; Xinxin Li; Fengyun Wang; Tao Wang; Qingfang Yuan; Sunwei Wang; Mengjia Pu; Guangjun Xi
Journal:  Neurol Sci       Date:  2018-06-05       Impact factor: 3.307

3.  Inhibiting HMGB1 Reduces Cerebral Ischemia Reperfusion Injury in Diabetic Mice.

Authors:  Chong Wang; Jie Jiang; Xiuping Zhang; Linjie Song; Kai Sun; Ruxiang Xu
Journal:  Inflammation       Date:  2016-12       Impact factor: 4.092

Review 4.  Role of prediabetes in stroke.

Authors:  Milija D Mijajlović; Vuk M Aleksić; Nadežda M Šternić; Mihailo M Mirković; Natan M Bornstein
Journal:  Neuropsychiatr Dis Treat       Date:  2017-02-02       Impact factor: 2.570

Review 5.  Clinical Variables and Genetic Risk Factors Associated with the Acute Outcome of Ischemic Stroke: A Systematic Review.

Authors:  Nuria P Torres-Aguila; Caty Carrera; Elena Muiño; Natalia Cullell; Jara Cárcel-Márquez; Cristina Gallego-Fabrega; Jonathan González-Sánchez; Alejandro Bustamante; Pilar Delgado; Laura Ibañez; Laura Heitsch; Jerzy Krupinski; Joan Montaner; Joan Martí-Fàbregas; Carlos Cruchaga; Jin-Moo Lee; Israel Fernandez-Cadenas
Journal:  J Stroke       Date:  2019-09-30       Impact factor: 6.967

6.  Effect of Diabetes on Post-stroke Recovery: A Systematic Narrative Review.

Authors:  Seoyon Yang; Mathieu Boudier-Revéret; SuYeon Kwon; Min Yong Lee; Min Cheol Chang
Journal:  Front Neurol       Date:  2021-12-14       Impact factor: 4.003

7.  Association between Coronary Artery Spasm and the risk of incident Diabetes: A Nationwide population-based Cohort Study.

Authors:  Ming-Jui Hung; Nen-Chung Chang; Patrick Hu; Tien-Hsing Chen; Chun-Tai Mao; Chi-Tai Yeh; Ming-Yow Hung
Journal:  Int J Med Sci       Date:  2021-05-03       Impact factor: 3.738

Review 8.  Prevalence, Treatment, and Control of Hypercholesterolemia in High Cardiovascular Risk Patients: Evidences from a Systematic Literature Review in Spain.

Authors:  Alex de la Sierra; Xavier Pintó; Carlos Guijarro; José López Miranda; Daniel Callejo; Jesús Cuervo; Rudi Subirà; Marta Rubio
Journal:  Adv Ther       Date:  2015-10-26       Impact factor: 3.845

9.  Elevated Fasting Blood Glucose Is Predictive of Poor Outcome in Non-Diabetic Stroke Patients: A Sub-Group Analysis of SMART.

Authors:  Ming Yao; Jun Ni; Lixin Zhou; Bin Peng; Yicheng Zhu; Liying Cui
Journal:  PLoS One       Date:  2016-08-05       Impact factor: 3.240

Review 10.  Prevalence of diabetes and its effects on stroke outcomes: A meta-analysis and literature review.

Authors:  Lik-Hui Lau; Jeremy Lew; Karen Borschmann; Vincent Thijs; Elif I Ekinci
Journal:  J Diabetes Investig       Date:  2018-10-13       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.